Drug & intervention
brolucizumab
RxCUI 2204915
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
3 shownTo Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular EdemaNCT04058067 · 2019-08-23
COMPLETEDEfficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaNCT03917472 · 2019-07-17
COMPLETEDStudy of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaNCT03481634 · 2018-07-23
COMPLETEDConditions being studied
Research locations
AustinTexas, United States2Beverly HillsCalifornia, United States2ClevelandOhio, United States2HaifaIsrael2HoustonTexas, United States2IndianapolisIndiana, United States2Kfar SabaIsrael2MadisonWisconsin, United States2Petah TikvaIsrael2PhoenixArizona, United States2RenoNevada, United States2San AntonioTexas, United States2
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.